PATENT CLAIM ANALYSIS

Application Number: 16042475
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "464000"]

Abstract:
The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of autism spectrum disorders (ASD).

Claim (Index 1):
A method for the prevention or treatment of autism spectrum disorders (ASD) in an individual, comprising administering the individual a prophylactically or therapeutically active amount of at least one compound of the following formula (I): in which:\n n represents 1 or 2, \n A 1 , A 2  and A 3 , identical or different, represent a hydrogen atom, a halogen atom, or a linear or branched alkyl group having from 1 to 4 carbon atoms, \n R 1 , R 2  and R 3 , identical or different represent a hydrogen atom or a linear or branched alkyl group having from 1 to 4 carbon atoms, and \n Y represents \u2014OH, \u2550O or \u2014SH; \n or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 95.0
- Lexical Diversity: 1.19355
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15004218', '15869672', '15038011', '13699087', '15687111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7099022233873707
- 35 USC 102 Novelty (BERT): 0.509522361827461
- Combined Prediction Score: 0.6898642372313798
- Mean Citation Score: 212.190992
- Max Citation Score: 225.72235
- Similarity Product: 144.77365556454657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test